Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03265353 · ClinicalTrials.gov registry record · NA
Vascular Effects of Dietary Potassium
A NA study, sponsored by University of Delaware.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
NCT03265353: Completed NA study, sponsored by University of Delaware.
NCT03265353 is a NA study that has completed, run by University of Delaware. The registered enrollment target is 47 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03265353, a NA study, has completed, sponsored by University of Delaware.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if dietary potassium can attenuate the deleterious effects of high sodium on blood vessel function in healthy, salt-resistant participants.
Primary Outcome
The change in flow-mediated dilation (FMD) between the 3 diets as assessed by brachial artery FMD
Interventions
- OTHER Moderate Potassium/Low Sodium Diet
- OTHER Moderate Potassium/High Sodium Diet
- OTHER High Potassium/High Sodium Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2013-07-25 |
| Est. Completion | 2019-09-22 |
| Phase | NA |
What the finished NCT03265353 record still lists
NCT03265353 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 47 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 3 interventions - of which Moderate Potassium/Low Sodium Diet is the first listed.
NCT03265353 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03265353 about?
NCT03265353 is a clinical study titled "Vascular Effects of Dietary Potassium". The purpose of this study is to determine if dietary potassium can attenuate the deleterious effects of high sodium on blood vessel function in healthy, salt-resistant participants.
What is the current status of trial NCT03265353?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2013-07-25. Estimated completion is 2019-09-22.
What interventions are being tested in trial NCT03265353?
The interventions under investigation include: Moderate Potassium/Low Sodium Diet (OTHER), Moderate Potassium/High Sodium Diet (OTHER), High Potassium/High Sodium Diet (OTHER).
Who is sponsoring clinical trial NCT03265353?
This trial is sponsored by University of Delaware, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03265353's enrollment target sits among peer trials
47 1400th of 2000 higher than 599 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03313011 · 47 participants
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
- NCT03467516 · 47 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
- NCT03886662 · 47 participants · Phase 1
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- NCT04013802 · 47 participants · Phase 1
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI